1,786
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7

, , , &
Pages 1152-1162 | Received 16 Sep 2014, Accepted 15 Dec 2014, Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Farheen Fatima Qizilbash, Ali Sartaj, Zufika Qamar, Shobhit Kumar, Mohammad Imran, Yousuf Mohammed, Javed Ali, Sanjula Baboota & Asgar Ali. (2023) Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting 31:8, pages 794-816.
Read now
Yu. A. Tereshkina, T. I. Torkhovskaya, E. G. Tikhonova, L. V. Kostryukova, M. A. Sanzhakov, E. I. Korotkevich, Yu. Yu. Khudoklinova, N. A. Orlova & E. F. Kolesanova. (2022) Nanoliposomes as drug delivery systems: safety concerns. Journal of Drug Targeting 30:3, pages 313-325.
Read now
Xiang Li, Qian Zou, Jing Zhang, Peng Zhang, Xiong Zhou, Satya Siva Kishan Yalamarty, Xinli Liang, Yali Liu, Qin Zheng & Jianqing Gao. (2020) Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer. International Journal of Nanomedicine 15, pages 6791-6811.
Read now
Jigar Vanza, Parva Jani, Nilima Pandya & Hemal Tandel. (2018) Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design. Drug Development and Industrial Pharmacy 44:6, pages 923-933.
Read now
Yi Huang, Qi Tao, Dongzhi Hou, Sheng Hu, Shuangyan Tian, Yanzhong Chen, Ruyi Gui, Lingling Yang & Yao Wang. (2017) A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride. International Journal of Nanomedicine 12, pages 1731-1745.
Read now
Hassan Bardania, Shabnam Tarvirdipour & Farid Dorkoosh. (2017) Liposome-targeted delivery for highly potent drugs. Artificial Cells, Nanomedicine, and Biotechnology 45:8, pages 1478-1489.
Read now
Jun Chen, Junhong Yao, Zhuyue Ma, Pei Peng, Shanshan Lu, Yudong Hu, Fei Xu, Yang Yang & Xixiong Yang. (2017) Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition. Journal of Liposome Research 27:1, pages 21-31.
Read now

Articles from other publishers (12)

Wenjuan Li, Shanhe Li, Gang Xu, Xueyu Man, Tongfu Yang, Zhenlei Zhang, Hong Liang & Feng Yang. (2023) Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis. Journal of Medicinal Chemistry.
Crossref
Mehrab Pourmadadi, Shima Ostovar, Gustavo Ruiz-Pulido, Dilawar Hassan, Maryam Souri, Amanda-Lee Ezra Manicum, Razieh Behzadmehr, Sonia Fathi-karkan, Abbas Rahdar, Dora I. Medina & Sadanand Pandey. (2023) Novel epirubicin-loaded nanoformulations: Advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery. Inorganic Chemistry Communications 155, pages 110999.
Crossref
Janske Nel, Kamil Elkhoury, Émilie Velot, Arnaud Bianchi, Samir Acherar, Grégory Francius, Ali Tamayol, Stéphanie Grandemange & Elmira Arab-Tehrany. (2023) Functionalized liposomes for targeted breast cancer drug delivery. Bioactive Materials 24, pages 401-437.
Crossref
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye & Bhushan P. Chaudhari. (2023) Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids 250, pages 105258.
Crossref
Jigar D. Vanza, Dhwani M. Shah, Rashmin B. Patel & Mrunali R. Patel. (2022) Afatinib liposomal dry powder inhaler: Targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer. Journal of Drug Delivery Science and Technology 74, pages 103506.
Crossref
Ridam Kapoor, Anamika Saini & Deepika Sharma. (2022) Indispensable role of microbes in anticancer drugs and discovery trends. Applied Microbiology and Biotechnology 106:13-16, pages 4885-4906.
Crossref
Giulia Remaggi, Ovidio Catanzano, Fabiana Quaglia & Lisa Elviri. (2022) Alginate Self-Crosslinking Ink for 3D Extrusion-Based Cryoprinting and Application for Epirubicin-HCl Delivery on MCF-7 Cells. Molecules 27:3, pages 882.
Crossref
Martina Di Francesco, Christian Celia, Maria Chiara Cristiano, Nicola d’Avanzo, Barbara Ruozi, Constantin Mircioiu, Donato Cosco, Luisa Di Marzio & Massimo Fresta. (2021) Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer. ACS Omega 6:4, pages 2973-2989.
Crossref
Mariza Aires Fernandes, Josimar O. Eloy, Marcela Tavares Luiz, Sergio Luiz Ramos Junior, Júlio César Borges, Laura Rodríguez de la Fuente, Clara Ortega-de San Luis, Juliana Maldonado Marchetti, Maria J. Santos-Martinez & Marlus Chorilli. (2021) Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 611, pages 125806.
Crossref
Shashank Chaturvedi & Kamla Pathak. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 299 318 .
Lin Ding, Wenxing Gu, Yifan Zhang, Shujing Yue, Huanli Sun, Jeroen J. L. M. Cornelissen & Zhiyuan Zhong. (2019) HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor. Biomacromolecules 20:10, pages 3855-3863.
Crossref
Selvaraj Kunjiappan, Theivendran Panneerselvam, Balasubramanian Somasundaram, Sankarganesh Arunachalam, Murugesan Sankaranarayanan & Pavadai Parasuraman. (2018) Preparation of liposomes encapsulated Epirubicin-gold nanoparticles for Tumor specific delivery and release. Biomedical Physics & Engineering Express 4:4, pages 045027.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.